Published on 18 Feb 2024 on Simply Wall St. via Yahoo Finance
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Reported And Analysts Have Been Cutting Their...
Investors in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) had a good week, as its shares rose 5.4% to close at US$26.51 following the release of its yearly results. It was a moderately negative result overall - revenue fell 3.2% short of analyst estimates at US$27m, and statutory losses were in line with analyst expectations, at US$6.33 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
Check out our latest analysis for Agios Pharmaceuticals
